Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
about
sameAs
Renin-angiotensin system blockade: Its contribution and controversyA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareRole and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastasesGPCRs and cancerTelmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells.Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.Nanostructured Pt(NH(3))(4)Cl(2)/SiO(2) for nanomedicine: catalytic degradation of DNA in cancer cellsMarketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinomaAngiotensin peptides and lung cancer.Manipulating the angiotensin system--new approaches to the treatment of solid tumours.Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulationThe prince and the pauper. A tale of anticancer targeted agents.Role of renin-angiotensin system in gastric oncogenesis.Angiotensin inhibition and malignancies: a review.Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.Will β-blockers live up to the maxim of Sir James Black, their creator?Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment.Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab.Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma.Cell type specificity of signaling: view from membrane receptors distribution and their downstream transduction networks.Effect of AT1R knockdown on ishikawa cell proliferation induced by estrogen.Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer.
P2860
Q26827221-0FD43976-0624-410F-8A8D-E9417B2DCD07Q26851160-A33DBDE1-1310-4AE4-9A80-F02897CDD49AQ28084420-CE5D1812-6408-4626-B1B2-EDFC70E6633AQ33828719-48A4AD11-2BB4-4FB3-AC02-67F57483E42CQ34433686-E9778955-69FB-4E0A-BF04-9DBFB96EB075Q35082610-40BF0541-7690-4C94-83AB-0A0CBFD32209Q35388346-C1CC1D2C-FACA-477F-9DEC-A8D7B4536A8AQ35547337-B624A32C-0939-49E7-B3D1-F4F60EA24423Q35653603-30EBCCCA-F5A2-41CE-B6A7-B8F8FECB1F8FQ35681985-E74BCE4A-F4EA-4964-98E7-3A0E1A2C428AQ35857462-F0339F6F-E2BC-41A8-A0ED-202F392610B4Q36407240-2323E11A-373E-4B2B-A451-9244F79DE083Q36613817-5B55CA8C-33CE-4A30-9BE1-CF95EF55831AQ36755237-9F6B1FA1-4F15-4B5C-8FDB-076A49EBA6C1Q36965424-3C80140B-3293-45DE-9780-30A4E71D290AQ37042365-8B0C4D81-F628-42AB-B1E5-198B05CF46C4Q37084550-FCFB9C0A-9B19-47C4-B79D-0135CD44E187Q37429773-CA6EEBF4-4B6F-4C1D-91BE-2DC8427BEED6Q37864617-1380E100-2A11-47B7-92DC-8153AB0D12B0Q38020388-2D527E45-BAA5-42FE-AC8E-B387D5725DE4Q38226775-8E8CCB38-7781-41EC-B6FD-6746B165862DQ38294600-7BF9075B-F5AD-4941-B53A-3B39AE3F3894Q38587724-7DDE7659-BCE2-4546-BD4E-7DCCEEACE2EDQ38718044-694408FB-CEBE-456F-9E40-F8CB9A3E7A7BQ38981634-9C527EF4-DE14-4BBE-87C7-9F4AA080E3F1Q39313461-9A8721AC-8E1A-46B4-953D-450D25F64F69Q39367916-90A3B79F-B284-4520-BAB7-8D51CBEC52A5Q41686732-E2DD8219-B775-4CD3-9FEC-4B1D0DE88B57Q49015944-DDE76DF6-5A9C-45DE-AD31-3AAF3AAA38EAQ53612763-80739030-1773-4E33-8672-B242836570F7Q54365845-12469A45-BF3B-4666-9FF9-E1C56603AC75
P2860
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@ast
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@en
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@nl
type
label
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@ast
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@en
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@nl
prefLabel
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@ast
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@en
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@nl
P2093
P2860
P356
P1476
Blockage of angiotensin II typ ...... ltured cells and C6 rat glioma
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602483
P407
P577
2005-04-01T00:00:00Z
P5875
P6179
1051131823